GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities

Recent data suggests that use of GLP-1s is highest for perimenopausal women in the United States. Despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose in this population. Full article here.

.